Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil effects on LV function in diastolic dysfunction
NCT04117009Phase 4Unknown
- Sponsor
- Yeditepe University
- Start
- Nov 2019
- Primary completion
- Jun 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remifentanil, sponsored by Yeditepe University. Primary endpoint: Change in diastolic function from the baseline value. Status: unknown.
02
Drugs
remifentanil
Beyond the preview
Go deeper on NCT04117009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04117009.